MetLife and Darling Ingredients Announce $4 Billion in Combined Share Buybacks

Key Facts

In a move reflecting the commitment of US corporations to enhancing shareholder value, MetLife and Darling Ingredients announced new share repurchase authorizations totaling $4 billion. MetLife's board approved a new $3 billion authorization, while Darling Ingredients increased its existing program to $1 billion. The companies cited robust balance sheets, accelerating cash generation, and long-term strategic confidence as the primary drivers for returning capital to investors.

These financial maneuvers serve as a positive indicator of corporate solvency within the insurance and bio-ingredients sectors, aiming to reduce share supply and support market valuations. Per market data, MET shares closed at $96.13 on August 4, 2026, having traded between a session low of $93.91 and a high of $96.44 during that period.

Traders should watch the price action of MET, which stood at $96.13 (close August 4, 2026), to gauge market reception of these capital returns. With no major upcoming catalysts for these specific instruments in the next seven days according to the economic calendar, focus remains on the execution of these buybacks and their impact on earnings per share in future quarters.